Chemcon _- Bad results ( No production for 22 days in Dec) Dislosure - Invested
Chemcon Good Results-fixed asset from 65 to 81 cr,cwip 34 cr ,Cash bank balance and cash eq almost 225 cr ,long term debt almost nil,cfo 75 cr
Chemcon speciality- Good results, good margins, first dividend of 4 rs .
Chemcon speciality-
We are glad to report that we have successfully launched production of CMIC and TMCS at P8 facility at Manjusar.
The Company has added 2,400 MTPA of TMCS and 1,200 MTPA of CMIC. We are now the largest manufacturer of CMIC in the world with a total capacity
We are glad to report that we have successfully launched production of CMIC and TMCS at P8 facility at Manjusar.
The Company has added 2,400 MTPA of TMCS and 1,200 MTPA of CMIC. We are now the largest manufacturer of CMIC in the world with a total capacity
of 3,000 MTPA.
Commercial production of P9 has been delayed by couple of months and expected to commercialize in Q2FY23.
We will add few existing products and few new products at P9 unit.
On the other hand, we are happy to announce that we have started mechanical construction
Commercial production of P9 has been delayed by couple of months and expected to commercialize in Q2FY23.
We will add few existing products and few new products at P9 unit.
On the other hand, we are happy to announce that we have started mechanical construction
On the other hand, we are happy to announce that we have started mechanical construction of P10 at the same location for other pharma intermediate products. Commercial production of P10 is expected to commence by end of this financial year.
Chemcon speciality chemicals- capacity addition of new product Bromo Benzene .
The Global Bromobenzene Market was valued at US$ 57.6 Mn in 2020. It is expected to reach US$ 96.2 Mn by 2028 and exhibit a CAGR of 5.4% during the forecast period (2021-2028).( in Listed players Heranba also manufacturers Bromobenzene.
Loading suggestions...